MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants
Since the coronavirus disease outbreak in 2019, several antibody therapeutics have been developed to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Antibody therapeutics are effective in neutralizing the virus and reducing hospitalization in patients with mild and mod...
Enregistré dans:
Auteurs principaux: | Sua Lee, Shina Jang, Jihoon Kang, Soo Bin Park, Young Woo Han, Hyemi Nam, Munkyung Kim, Jeewon Lee, Ki Joon Cho, Jeonghun Kim, Miyoung Oh, Jihye Ryu, Jong Hyeon Seok, Yunhwa Kim, Jee-Boong Lee, Man-Seong Park, Yong-Sung Kim, Hosun Park, Dong-Sik Kim |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7e740e1bfe9248e3844839c81b27bd6d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Analysis of COVID-19 outbreak origin in China in 2019 using differentiation method for unusual epidemiological events
par: Radosavljevic Vladan
Publié: (2021) -
Acta N°1141
par: Banco Central de Chile
Publié: (2021) -
Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe Disease
par: Ji Yeon Lee, et autres
Publié: (2021) -
Habitat utilization of two muroid species in relation to population outbreaks in southern temperate forests of Chile
par: GONZALEZ,LUZ A, et autres
Publié: (2000) -
Delays in the diagnosis and treatment of tuberculosis during the COVID-19 outbreak in the Republic of Korea in 2020
par: Jiyeon Yang, et autres
Publié: (2021)